These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. [The value of angiotensin-converting enzyme inhibitors in the treatment of hypertension]. Klaus D. Z Kardiol; 1988 Oct; 77 Suppl 3():73-88. PubMed ID: 3062960 [Abstract] [Full Text] [Related]
10. Renal effects of angiotensin-converting enzyme inhibitors that result in cost savings and improved patient outcomes. Swislocki AL, Siegel D. Am J Manag Care; 2001 Mar; 7(3):283-95. PubMed ID: 11258145 [Abstract] [Full Text] [Related]
14. Angiotensin converting enzyme inhibition and renal insufficiency in patients with bilateral renovascular disease. Dominiczak A, Isles C, Gillen G, Brown JJ. J Hum Hypertens; 1988 Jun; 2(1):53-6. PubMed ID: 3070034 [Abstract] [Full Text] [Related]
15. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance? Vogt L, Kocks MJ, Laverman GD, Navis G. Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515 [Abstract] [Full Text] [Related]
17. [Renal side effects of angiotensin converting enzyme inhibitors]. Schmidt A, Mayer G. Wien Med Wochenschr; 1996 Oct; 146(16):454-6. PubMed ID: 9036683 [Abstract] [Full Text] [Related]